NCT03161145View on ClinicalTrials.gov

A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

CompletedOBSERVATIONAL
Enrollment

297

Participants

Timeline

Start Date

December 9, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Renal Cell Carcinoma
Trial Locations (1)

1070052

Local Institution, Tokyo

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT03161145 - A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread | Biotech Hunter | Biotech Hunter